Par Drugs and Chemicals (NSE:PAR) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Investors were disappointed with Par Drugs and Chemicals Limited's (NSE:PAR) earnings, despite the strong profit numbers. We did some digging and found some worrying underlying problems.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

How Do Unusual Items Influence Profit?

To properly understand Par Drugs and Chemicals' profit results, we need to consider the ₹21m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. Which is hardly surprising, given the name. If Par Drugs and Chemicals doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Par Drugs and Chemicals.

Our Take On Par Drugs and Chemicals' Profit Performance

Arguably, Par Drugs and Chemicals' statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Par Drugs and Chemicals' statutory profits are better than its underlying earnings power. The good news is that, its earnings per share increased by 34% in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. To help with this, we've discovered 2 warning signs (1 is a bit unpleasant!) that you ought to be aware of before buying any shares in Par Drugs and Chemicals.

This note has only looked at a single factor that sheds light on the nature of Par Drugs and Chemicals' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.